Bipartisan bill seeks to stop pharmacy middlemen from driving up drug costs for financial gain
Act" was unveiled by a group of bipartisan lawmakers Tuesday, aimed at reforming the incentive structure for Pharmacy Benefit ...
Michigan baseball player apologizes for drug-inspired celebration
Michigan infielder Mitchell Voit was feeling good during Sunday’s 11-0 victory over USC. So good that when he legged out a ...
Florida demands patient names, prescriptions from drug middlemen
The Office of Insurance Regulation is demanding the unusual trove of data from pharmacy benefit managers — health care ...
Facts, not fear: Inside Mexico’s pioneering drug harm reduction programs
Since the mid-1980s, a number of organizations, primarily in northern Mexico, have launched informational campaigns and ...
Trump's tariffs, trade war with China could worsen prescription drug shortages in US
As President Donald Trump on Thursday contemplated extending a global trade war to imports from Europe, the health-care ...
Employers Get Big Drug Discounts Through Program For Hospitals That Serve Poor Patients
The government program, known as 340B, allows hospitals that care for many uninsured and low-income patients to purchase ...
Maryland lawmakers considering legislation to help cover patient medications
Senate Bill 773 and House Bill 1246 would require insurance companies to apply assistance toward a patient's deductible, ...
Generation Xanax: The Dark Side of America’s Wonder Drug
Amid rising concerns about benzodiazepines, some patients who try to quit are suffering extreme anxiety, memory loss and ...
What Companies Can Do To Address Prescription Drug Market Manipulation
If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.
Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers
Patanjali’s Renogrit effectively mitigates kidney damage caused by the cancer drug cisplatin, according to a study published ...
Mother with rare ALS touts 'miracle drug' that has stopped her disease
Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017. Since starting a clinical trial nearly eight years ago, her symptoms have not gotten any worse.
Michigan baseball player apologizes after drug-inspired celebration: ‘An immature decision’
Michigan infielder Mitchell Voit apologized for what he called an "immature decision" after he celebrated a play with a ...